{
  "id": 19720866,
  "title": "Earnings call transcript: U.S. Antimony misses Q3 2026 estimates as shares fall",
  "url": "https://urgent.news/2026/11/12/earnings-call-transcript-u-s-antimony-misses-q3-2026-estimates-as",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-12T22:52:08.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-us-antimony-misses-q3-2026-estimates-as-shares-fall-93CH-5023601"
  },
  "original_language": "en",
  "account": "U.S. Antimony reported a narrower-than-expected third-quarter loss but fell short of revenue estimates, causing its shares to drop in after-hours trading. The company posted a loss of 6 cents per share, exceeding analysts' projections of 2 cents, while revenue came in at $10.13 million, below the anticipated $16.72 million. Despite a 68% year-over-year increase in antimony sales volumes, the stock declined 6.73% in regular trading and another 8.93% in after-hours trading, reaching a low near its 52-week range. Revenue rose 16% year-over-year and 28% sequentially, while gross profit more than doubled and gross margin expanded to 42% from 23%. The company's cash reserves stood at $51 million, and it had no debt drawn. Management adjusted guidance to volume-based due to antimony price volatility, and the company expects 2026 sales of 1.68 million to 1.81 million pounds, up 24% from 2025.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}